公众号 / 文章泌尿生殖MR

前列腺影像报告和数据系统第2版用于前列腺癌MRI:能否做得更好?

Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better?
PubMed 文献 · AJR Am J Roentgenol · 2019-03-19

本文旨在评述前列腺影像报告和数据系统第2版(PI-RADSv2)的优势与不足,并讨论改进方向。PI-RADSv2改善了前列腺MR图像采集与解读的标准化,提高了临床显著癌的检出,但其主观性和阅片者内变异限制了准确性和可重复性,引发对其可靠性的担忧。

要点

  • PI-RADSv2改善了前列腺MR采集与解读的标准化。
  • PI-RADSv2提高了临床显著癌的检出。
  • PI-RADSv2的主观性和阅片者内变异限制其准确性和可重复性。

核心结论

  • PI-RADSv2改善了前列腺MR图像采集与解读的标准化,提高了临床显著癌的检出,但其主观性和阅片者内变异限制其准确性和可重复性,引发对其可靠性的担忧。

研究设计与样本

  • 本文为对PI-RADSv2的述评,旨在突出其优势与不足并讨论改进方式,原文未报告系统检索范围与纳入文献。

局限性

  • PI-RADSv2具有明确局限性,其主观性和阅片者内变异限制其准确性和可重复性,引发对其可靠性的担忧。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. Although the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) has been widely adopted and is generally considered a success, it has clear limitations. The purpose of this article is to highlight the strengths and weaknesses of PI-RADSv2 and discuss ways that it can be improved. CONCLUSION. PI-RADSv2 has improved standardization of acquisition and interpretation of prostate MR images. Although it improves the detection of clinically significant cancers, its subjectivity and intrareader variability limit its accuracy and reproducibility, causing concerns regarding its reliability.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Sackett J, Choyke PL, Turkbey B, et al. Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better? AJR Am J Roentgenol. 2019. PMID: 30888865. doi:10.2214/AJR.19.21178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。